Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Click here for the RSS feed for Publications IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Page 1 of 13
Date Title
17/05/2013 Avastin (bevacizumab) Important Safety Information from Roche as approved by the Irish Medicines Board
17/05/2013 Synacthen (tetracosactide) Important Safety Information from SOBI AB as approved by the Irish Medicines Board
15/05/2013 Protelos (strontium ranelate) Important Safety Information from Servier as approved by the Irish Medicines Board
07/05/2013 Increlex (mecasermin) Important Safety Information from Ipsen as approved by the Irish Medicines Board
03/05/2013 Fastum Gel (ketoprofen) Important Safety Information from A. Menarini as approved by the Irish Medicines Board
19/04/2013 Thalidomide Celgene (thalidomide) Important Safety Information from Celgene as approved by the Irish Medicines Board
15/04/2013 MabThera (rituximab) Important Safety Information from Roche Products (Ireland) Limited as approved by the Irish Medicines Board
09/04/2013 Incivo (telaprevir) Important Safety Information from Janssen as approved by the Irish Medicines Board
27/03/2013 Mimpara (cinacalcet) Important Safety Information from Amgen Ireland Limited as approved by the Irish Medicines Board
20/03/2013 Nulojix (belatacept) Important Safety Information from Bristol-Myers Squibb Pharmaceuticals as approved by the Irish Medicines Board
05/03/2013 Vistide (Cidofovir) Important Safety Information from Gilead Sciences International Limited as approved by the Irish Medicines Board
26/02/2013 NeuroBloc (Botulinum Toxin Type B) Important Safety Information from Eisai Ltd as approved by the Irish Medicines Board
21/02/2013 Prolia (denosumab) Important Safety Information from Amgen Ireland Limited as approved by the Irish Medicines Board
04/02/2013 Xagrid (anagrelide hydrochloride) - Important Safety Information from Shire as approved by the Irish Medicines Board
24/01/2013 Tredaptive (nicotinic acid/laropiprant) - Important Safety Information from Merck Sharp & Dohme as approved by the Irish Medicines Board
17/01/2013 Tisseel Lyo, Tisseel Ready to use and Artiss Solutions for Sealant (Human Fibrinogen) - Important Safety Information from Baxter as approved by the Irish Medicines Board
14/01/2013 Gilenya (fingolimod) - Important Safety Information from Novartis Ireland Ltd as approved by the Irish Medicines Board
11/01/2013 Tredaptive (nicotinic acid/laropiprant) - Important Safety Information from Irish Medicines Board
09/01/2013 Revlimid (lenalidomide) - Important Safety Information from Celgene as approved by the Irish Medicines Board
08/01/2013 Tredaptive (nicotinic acid/laropiprant) - Important Safety Information from Merck Sharp & Dohme as approved by the Irish Medicines Board
Page 1 of 13



Date Printed: 26 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971